QUIA PHARMA AB (OSTO:QUIA) ROCE % : -169.29% (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is QUIA PHARMA AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. QUIA PHARMA AB's annualized ROCE % for the quarter that ended in Dec. 2024 was -169.29%.

QUIA PHARMA AB ROCE % Historical Data

The historical data trend for QUIA PHARMA AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QUIA PHARMA AB ROCE % Chart

QUIA PHARMA AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-806.40

-192.41

-91.13

-94.37

-181.39

QUIA PHARMA AB Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROCE %	Get a 7-Day Free Trial															-61.39	-94.83	-72.98	-56.62	-169.29

QUIA PHARMA AB ROCE % Calculation

QUIA PHARMA AB's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-28.664	/	( ( (41.959 - 26.708)	+	(22.749 - 6.395) )	/ 2 )
	=	-28.664	/	( (15.251	+	16.354)	/ 2 )
	=	-28.664	/	15.8025
	=	-181.39 %

QUIA PHARMA AB's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Jun. 2024 )		(Q: Dec. 2024 )
	=	-43.194	/	( ( (42.566 - 7.89)	+	(22.749 - 6.395) )	/ 2 )
	=	-43.194	/	( ( 34.676	+	16.354 )	/ 2 )
	=	-43.194	/	25.515
	=	-169.29 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2024) EBIT data.

QUIA PHARMA AB (OSTO:QUIA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

QUIA PHARMA AB ROCE % Related Terms

Thank you for viewing the detailed overview of QUIA PHARMA AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

QUIA PHARMA AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » QUIA PHARMA AB (OSTO:QUIA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

99B0:Germany

Address

Virdings Alle 32 B, Uppsala, SWE, 754 50

Website

https://www.quiapeg.com

QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.

QUIA PHARMA AB Headlines

No Headlines